Medicaid Managed Care Open Enrollment Extended through Dec. 15
Current Suspected Overdose Deaths in Delaware for 2017: 227
On April 12, 2013 the Centers for Disease Control and Prevention (CDC) announced a nationwide shortage of Tubersol®, one of two Purified Protein Derivative (PPD) tuberculin used in the Tuberculin Skin Test (TST) to diagnose TB infection. A shortage of Aplisol®, the second brand of PPD solution, was announced shortly after.
The shortage of PPD solution has now ended. The shortage of PPD solution Aplisol® was resolved May 2014, and the PPD solution Tubersol® was resolved in July 2014.
Resume testing in keeping with usual protocols.
Active TB disease is a legally reportable illness in Delaware, and the majority of cases are treated by specialists in DPH TB Clinics. To report a case of active TB, please contact the TB Clinic in your county or the TB Program.